The global Animal-derived Immune Globulin market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from 2.6bn in 2015 to 4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on Chinas Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of Chinas pet medical market is about 67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 228%.

Infinity Market Research newest research report, the Animal-derived Immune Globulin Industry Forecast looks at past sales and reviews total world Animal-derived Immune Globulin sales in 2024, providing a comprehensive analysis by region and market sector of projected Animal-derived Immune Globulin sales for 2025 through 2031. With Animal-derived Immune Globulin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Animal-derived Immune Globulin industry.

This Insight Report provides a comprehensive analysis of the global Animal-derived Immune Globulin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Animal-derived Immune Globulin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Animal-derived Immune Globulin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Animal-derived Immune Globulin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Animal-derived Immune Globulin.

This report presents a comprehensive overview, market shares, and growth opportunities of Animal-derived Immune Globulin market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Liquid
    Powder

Segmentation by Application:

    Hospital
    Clinic

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Pfizer
    Rare Disease Therapeutics
    Merck
    Sanofi
    Wyeth Pharmaceuticals
    Protherics
    Genzyme

Key Questions Addressed in this Report

What is the 10-year outlook for the global Animal-derived Immune Globulin market?
What factors are driving Animal-derived Immune Globulin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Animal-derived Immune Globulin market opportunities vary by end market size?
How does Animal-derived Immune Globulin break out by Type, by Application?